Trial Profile

A multi-center, randomized, double-blind, double-dummy study in postmenopausal women with low bone mineral density to compare the effects of a single dose of i.v. [intravenous] zoledronic acid 5 mg, with daily oral raloxifene 60 mg OD [once daily] on bone turnover markers.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Sep 2009 Results presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
16 Dec 2008 Actual trial completion date identified as July 2008 from ClinicalTrials.gov.
16 Dec 2008 Actual patient number identified as 110 from ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com